Parkinson's Disease Trial, Not Yet Recruiting NCT06849414 Sponsor: Assiut University Condition: Parkinson's Disease
Back to Parkinsons Disease

Parkinson's Disease Trial, Not Yet Recruiting

NCT06849414
Not Yet Recruiting Not Applicable

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • People who are inpatients or outpatients at the Movement Disorders clinic at the Neuropsychiatry Hospital of Assiut University.
  • People who are over 40 years of age.

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People whose Parkinson's-like symptoms are caused by a specific known cause, such as an infection, a medication, poisoning, hardening of the arteries in the brain, or a head injury.
  • People who have Parkinson's alongside another brain-degenerating condition, specifically Multiple System Atrophy, Progressive Supranuclear Palsy, or Dementia with Lewy Bodies.
  • People who had noticeable memory or thinking problems before their Parkinson's symptoms began, as reported by the person themselves or their family.
  • People who have significant abnormal findings in the brain detected on an MRI scan.
  • People who are unable to cooperate with completing clinical assessments and providing a blood sample.
  • People who are currently taking or have recently taken certain medications — such as anti-seizure drugs or certain chemotherapy drugs — that can affect a substance in the blood called homocysteine (Hcy), or people who have a thyroid condition or kidney problems that affect how the body processes that substance.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 24 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Not Yet Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
1 June 2025
Est. completion
1 June 2026

This date has passed while the registry still lists the trial as open to participants. Sponsors often update a trial's status without revising its projected end date, so it may well still be recruiting — but the record is out of date in at least one respect. Check with the study contact before relying on either.

Primary endpoints

To investigate the relationship between homocysteine level and motor as well as cognitive manifestation of Parkinson's disease patients

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 24 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov